Compass Therapeutics Correlations

CMPX Stock

USD 2.36 0.05 2.16%

The current 90-days correlation between Compass Therapeutics and AnaptysBio is 0.09 (i.e., Significant diversification). The correlation of Compass Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Compass Therapeutics Correlation With Market

Weak diversification

The correlation between Compass Therapeutics and DJI is 0.35 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Compass Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compass Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Compass Stock please use our How to Invest in Compass Therapeutics guide.

Moving together with Compass Stock

0.88	PLX	Protalix Biotherapeutics	Pair Corr
0.68	MLSS	Milestone Scientific Earnings Call This Week	Pair Corr
0.73	WM	Waste Management	Pair Corr
0.9	GE	GE Aerospace	Pair Corr
0.65	WMT	Walmart Aggressive Push	Pair Corr
0.78	CSCO	Cisco Systems	Pair Corr
0.85	MMM	3M Company	Pair Corr
0.82	JPM	JPMorgan Chase	Pair Corr
0.72	IBM	International Business	Pair Corr

Moving against Compass Stock

0.77	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.74	CDIO	Cardio Diagnostics	Pair Corr
0.52	ELVN	Enliven Therapeutics	Pair Corr
0.49	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.48	SCLX	Scilex Holding	Pair Corr
0.38	CDIOW	Cardio Diagnostics	Pair Corr
0.77	MRK	Merck Company	Pair Corr
0.34	MSFT	Microsoft	Pair Corr

Related Correlations Analysis

	IDYA	ANAB	MGTX	KROS	FIXX	GLUE	NAMS	IVA	CGEM	PEPG
IDYA		-0.44	-0.6	0.68	0.0	0.41	0.43	-0.82	0.92	0.5	IDYA
ANAB	-0.44		0.37	-0.51	0.0	-0.15	-0.52	0.46	-0.52	-0.56	ANAB
MGTX	-0.6	0.37		-0.4	0.0	-0.04	-0.37	0.66	-0.58	-0.38	MGTX
KROS	0.68	-0.51	-0.4		0.0	0.62	0.76	-0.47	0.76	0.91	KROS
FIXX	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	FIXX
GLUE	0.41	-0.15	-0.04	0.62	0.0		0.37	-0.22	0.51	0.43	GLUE
NAMS	0.43	-0.52	-0.37	0.76	0.0	0.37		-0.45	0.61	0.8	NAMS
IVA	-0.82	0.46	0.66	-0.47	0.0	-0.22	-0.45		-0.84	-0.35	IVA
CGEM	0.92	-0.52	-0.58	0.76	0.0	0.51	0.61	-0.84		0.61	CGEM
PEPG	0.5	-0.56	-0.38	0.91	0.0	0.43	0.8	-0.35	0.61		PEPG
	IDYA	ANAB	MGTX	KROS	FIXX	GLUE	NAMS	IVA	CGEM	PEPG

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CGEM	+ 0.92	IDYA
PEPG	+ 0.91	KROS
PEPG	+ 0.8	NAMS
NAMS	+ 0.76	KROS
CGEM	+ 0.76	KROS
KROS	+ 0.68	IDYA

High negative correlations

CGEM	- 0.84	IVA
IVA	- 0.82	IDYA
MGTX	- 0.6	IDYA
CGEM	- 0.58	MGTX
PEPG	- 0.56	ANAB
CGEM	- 0.52	ANAB

Risk-Adjusted Indicators

There is a big difference between Compass Stock performing well and Compass Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Compass Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
IDYA	2.30	(0.42)	0.00	(1.17)	0.00	0.00	4.11	(4.64)	12.18
ANAB	4.32	0.41	0.08	0.23	4.43	(5.41)	9.84	(7.48)	43.41
MGTX	3.13	0.40	0.13	(1.29)	3.41	(3.54)	5.56	(5.58)	34.28
KROS	2.63	(0.73)	0.00	9.16	0.00	0.00	4.41	(6.00)	19.64
FIXX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
GLUE	3.56	(0.22)	0.00	(0.26)	0.00	0.00	7.34	(7.69)	19.92
NAMS	2.16	(0.04)	0.00	0.05	0.00	0.00	6.09	(4.59)	13.71
IVA	2.97	0.35	0.09	0.29	3.36	(3.46)	5.84	(5.73)	23.67
CGEM	2.58	(0.40)	0.00	(0.73)	0.00	0.00	5.13	(6.43)	15.27
PEPG	8.31	(0.45)	0.00	(0.22)	0.00	0.00	19.62	(13.91)	92.48

Compass Therapeutics Corporate Management

Susan Kalled	Chief Officer	Profile
MD MBA	Chief Officer	Profile
Barry JD	Chief Officer	Profile
Neil CPA	Vice Finance	Profile
Peter Moesta	Interim CMC	Profile
Anna Gifford	Communications Manager	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC